Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation

Kidney International

Volumn 54, Issue 3, 1998, Pages 938-944

  Keown, P ^a   Niese, D ^a  

^a Building 210   (Switzerland)

Author keywords

Bioavailability of CsA; Drug tolerance; Graft survival; Immunosuppression; Pharmacokinetics

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CADAVER DONOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MULTICENTER STUDY; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0031660438     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00042.x     Document Type: Article

References (15)

1. B.D. Kahan Development of synergistic immunosuppressive drug regimens based upon cyclosporin Kidney Int 44 Suppl 43 1993 12 15
2. G. Tufveson B. Odlind A. SjÖBerg A. Lindberg J. Gabrielsson B. LindstrÖM H. Lithell I. Selinus T. TöTterman J. Wahlberg A longitudinal study of the pharmacokinetics of cyclosporin A and in vitro lymphocyte responses in renal transplant patients Transplant Proc 18 Suppl 5 1986 16 24
3. J.M. Kovarik E.A. Mueller J.B. Van BRee W. Tetzloff K. Kutz Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation J Pharm Sci 83 1994 444 446
4. J.M. Kovarik E.A. Mueller J.B. Van BRee S.S. FlÜCkiger H. Lange B. Schmidt W.H. Boesken A.E. Lison K. Kutz Cyclosporine pharmacokinetics and variability from a microemulsion formulation—A multicenter investigation in kidney transplant patients Transplantation 58 1994 658 663
5. 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporin in blood Clin Chem 34 1988 257 260
6. A. Lindholm B.D. Kahan Influence of cyclosporine pharmacokinetics, trough concentrations and AUC monitoring on outcome after kidney transplantation Clin Pharmacol Ther 54 1993 205 218
7. N.G. Best A.K. Trull K.K.C. Tan K.L. Hue D.J. Spiegelhalter S.M. Gore J. Wallwork Blood cyclosporin concentrations and the short term risk of lung rejection following heart-lung transplantation Br J Clin Pharmacol 34 1992 315 520
8. R.J. Tesi M.L. Henry E.A. Elkhammas D.L. Dunn W.D. Payne P. Gores R. Gruessner J.S. Najarian Predictors of long-term primary cadaveric renal transplant survival Clin Transplant 7 1993 345 352
9. P.S. Almond A. Matas K. Gillingham D.L. Dunn W.D. Payne P. Gores R. Gruessner J.S. Najarian Risk factors for chronic rejection in renal allograft recipients Transplantation 55 1993 752 757
10. J.M. Kovarik E.A. Mueller F. Richard D. Niese P.F. Halloran J. Jeffery L.C. Paul P.A. Keown Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant recipients receiving a microemulsion formulation Transplantation 62 1996 759 763
11. G. Barone C.M. Bunke M.G. Choc JR D.E. Hricik J.H. Jin J.B. Klein C.L. Marsh D.I. Min M.D. Pescovitz R. Pollak T.L. Pruett J.B. Stinson J.S. Thompson E. Vasquez T. Waid D.G. Wombolt R.L. Wong The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients Transplantation 61 1996 968 970
12. J.P. Lodge S.G. Pollard For The UK NEoral STudy GRoup Neoral vs. Sandimmun: Interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients Transplant Proc 79 1997 272 273
13. G. Barone C.T. Chang M.G. Choc JR J.B. Klein C.L. Marsh J.A. Meligeni D.I. Min M.D. Pescovitz R. Pollak T.L. Pruett J.B. Stinson J.S. Thompson E. Vasquez T. Waid D.G. Wombolt R.L. Wong The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients Transplantation 61 1996 875 880
14. D. Niese The INternational SAndimmun NEoral STudy GRoup A double blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: Results after 12 months Transplant Proc 27 1995 1849 1856
15. G. Offermann A. Korn For The GErman NEoral STudy GRoup Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment Transplant Proc 28 1996 2204 2206